Investing in companies, especially those based on cutting-edge technologies or innovative products/services can become a profitable business, but may carry unforeseen inconveniences. Beyond the numbers, quantitative business valuations and accounting audits, we provide high-quality qualitative risk assessment for pharmaceutical, beauty, foods manufacturing and biotech sectors.
We add the value that financial firms can not: the legal, toxicological/medical and technical evaluations. Because we know that some bright ideas shine only in the slide-show. Our deep knowledge of US Health and Environmental regulations allow as to anticipate possible liabilities saving hundreds of thousands dollars to your company due to futures lawsuits.
To obtain highly unbiased biotech & high-tech product valuation we work together with some of the finest Research Labs and Universities all over the world.
ST&T Risk Assessment is the advisory branch of ST&T Research Intl. focus on pharmaceutical, beauty, foods and biotech sectors across, lab services, clinical services, product development services, consumer studies and legal support. Ours is a service business. Founders and management are our clients.
We help pharmaceutical, cosmetics and bio-tech groups find, screen and execute strategically important acquisitions - both large and small as well as we assist in M&A processes. We provide discreet, independent and unbiased advice to help companies evaluate and acquire new technologies, complementary businesses or enter US market.
For private equity and venture capital firms, in a highly competitive market for good quality opportunities, we use our global corporate relationships and deep regulatory and toxicological understanding to help identify hazards and secure attractive acquisition and investment opportunities. Protecting our clients from future lawsuits due to product liability, misbranding or EPA/FDA/USDA regulatory issues is our main concern.